MSD, Illumina and Genea form the Global Fertility Alliance
8 June 2015 | By Victoria White
The Global Fertility Alliance is a new collaboration to advance excellence in fertility technologies within the assisted reproductive treatment laboratory...
List view / Grid view
News
Lab-on-a-Chip, Microfluidics, Point-of-Care Diagnostics and Global Health, The Road to Diagnostics Congress
8 June 2015 | By Select Biosciences
Select Biosciences is delighted to announce that its flagship congress now in its 7th year in San Diego, California, USA is being held September 28-30, 2015...
Organ-on-a-Chip and 3D-Printing in the Life Sciences Conference, Boston, July 8-9, 2015 features international roster of speakers.
8 June 2015 | By Select Biosciences
Select Biosciences is delighted to announce that its Organ-on-a-Chip and 3D-Printing in the Life Sciences Conference, Boston, July 8-9, 2015 features all the international key opinion leaders in the organ-on-a-chip/body-on-a-chip field as well as 3D-bioprinting fields...
Drug abuse triggers regulations to push the development of abuse-free opioid formulations
8 June 2015 | By Victoria White
A $10 billion market exists for a company able to develop a novel, targeted opioid therapy that excludes side effects such as addiction and constipation...
T cell exhaustion study has possible implications for cancer and antiviral therapies
4 June 2015 | By Victoria White
When the T cells of your immune system are forced to deal over time with cancer or a chronic infection, they can develop "T cell exhaustion"...
AmpliPhi’s bacteriophage manufacturing facility receives cGMP certification
4 June 2015 | By Victoria White
AmpliPhi's production facility in Ljubljana has been cleared by JAZMP to manufacture bacteriophages under current Good Manufacturing Practices standards...
VBI Vaccines presents data supporting the use of its eVLP platform to develop a novel HCV vaccine candidate
4 June 2015 | By Victoria White
VBI Vaccines has delivered a presentation that supports the potential use of its eVLP platform in the development of a novel Hepatitis C vaccine candidate...
Amended Celgene and bluebird bio collaboration to focus on the development of anti-BCMA products
4 June 2015 | By Victoria White
The existing global collaboration between Celgene and bluebird bio has been amended and restated to focus on developing product candidates targeting BCMA...
Triple treatment keeps lung cancer from coming back
4 June 2015 | By Victoria White
Lung cancer often returns and the recurring cancer is often resistant to the chemotherapy and other drugs that originally drove it into remission...
Inovio partners with GeneOne Life Science for MERS vaccine clinical development
3 June 2015 | By Victoria White
Inovio has said it will advance its DNA vaccine for MERS into a Phase I clinical trial in healthy volunteers in a collaboration with GeneOne Life Science...
MSD extends immuno-oncology collaboration with Agenus
3 June 2015 | By Victoria White
MSD has extended its existing collaborative research agreement with Agenus for the discovery and development of therapeutic antibodies...
Auspherix raises £6 million to progress novel antibiotics and establishes UK operations
3 June 2015 | By Victoria White
Auspherix has raised £6 million in a Series A venture financing and is establishing operations on the Stevenage Bioscience Catalyst site...
Anti-Ebola MVA vaccine produced on ProBioGen’s AGE1.CR cell line platform enters clinical trials
3 June 2015 | By Victoria White
An investigational vaccine against Ebola, produced on ProBioGen’s proprietary, continuous muscovy duck AGE1.CR cell line, has proceeded into clinical trials...
LDC and Qurient sign licence agreement to advance CDK7 inhibitors for the treatment of cancer
3 June 2015 | By Victoria White
LDC and Qurient have signed a licence deal providing Qurient with exclusive worldwide rights to a series of highly-selective CDK7 inhibitors...
Astellas and Anokion establish Kanyos Bio to develop products for type 1 diabetes and coeliac disease
2 June 2015 | By Victoria White
Astellas Pharma and Anokion are to collaborate in the fields of type 1 diabetes and coeliac disease by establishing new drug discovery company Kanyos Bio...
